Hotchkiss Richard S, Tinsley Kevin W, Karl Irene E
Department of Anesthesiology, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Scand J Infect Dis. 2003;35(9):585-92. doi: 10.1080/00365540310015692.
Sepsis is the leading cause of morbidity and mortality in critically ill patients in many intensive care units. The pathophysiology of organ failure and death in patients with sepsis remain elusive. This review focuses on recent advances in our understanding of the mechanisms of cell death in sepsis, the types of cells that are dying and the consequences on immunity. Extensive apoptotic death results in immune cell depletion and may compromise the ability of the patient to eradicate the primary infection and predispose to secondary nosocomial infections. Peripheral circulating lymphocyte apoptosis is also increased in patients with sepsis and correlates with the severity of the disease. In addition, recent evidence indicates that uptake of apoptotic cells impairs the immune function of surviving cells and contributes to immunosuppression. This new understanding of sepsis may lead to novel therapeutic approaches including pharmacological agents that block apoptosis.
脓毒症是许多重症监护病房中危重症患者发病和死亡的主要原因。脓毒症患者器官衰竭和死亡的病理生理学机制仍不清楚。本综述重点关注我们对脓毒症细胞死亡机制、死亡细胞类型及其对免疫影响的最新认识进展。广泛的凋亡性死亡导致免疫细胞耗竭,可能损害患者根除原发性感染的能力,并易发生继发性医院感染。脓毒症患者外周循环淋巴细胞凋亡也增加,且与疾病严重程度相关。此外,最近的证据表明,凋亡细胞的摄取会损害存活细胞的免疫功能,并导致免疫抑制。对脓毒症的这种新认识可能会带来新的治疗方法,包括阻断凋亡的药物。